Highly sensitive troponin assays — a two-edged sword?

Lee J Nedkoff, Michael S T Hobbs and Tom G Briffa
Med J Aust 2013; 198 (1): . || doi: 10.5694/mja12.11446
Published online: 21 January 2013

To the Editor: Scott and colleagues address the vexed issue of using highly sensitive (hs) cardiac troponin (cTn) assays to detect myocardial infarction (MI) and likely increases in hospitalisations.1 Greater numbers of MIs detected by hs-cTn assays also confound population surveillance of MI trends and our understanding of disease prevention.

  • Lee J Nedkoff
  • Michael S T Hobbs
  • Tom G Briffa

  • Cardiovascular Research Group, School of Population Health, University of Western Australia, Perth, WA.


Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.